GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort ; volume:149 ; number:10 ; day:20 ; month:3 ; year:2023 ; pages:7405-7412 ; date:8.2023
Journal of cancer research and clinical oncology ; 149, Heft 10 (20.3.2023), 7405-7412, 8.2023

Creator: Dunn, Paul J.
Griffiths, Lyn R.
Yates, Patsy
Haupt, Larisa M.
Alexander, Kim E.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00432-023-04677-3

URN: urn:nbn:de:101:1-2023103012493675019604

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dunn, Paul J.
Griffiths, Lyn R.
Yates, Patsy
Haupt, Larisa M.
Alexander, Kim E.
SpringerLink (Online service)

Other Objects (12)

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Hochschulschrift

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Hochschulschrift

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Hochschulschrift

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Informative gene network for chemotherapy-induced peripheral neuropathy

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy

Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy

Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Related objects

Reset password